NEW YORK ─ Hologic on Monday said that the World Health Organization has granted prequalification approval for its Aptima HIV-1 Quant Dx assay for the testing of dried blood spot samples.
Separately, the Marlborough, Massachusetts-based company announced a private offering of senior notes due in 2029 in the aggregated principal amount of $950 million.